Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: -0.50 (-1.67%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 29.50
Prev. Close: 30.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

15 Jan 2014 07:00

RNS Number : 6535X
Ilika plc
15 January 2014
 



Ilika plc

('Ilika,' the 'Company,' or the 'Group')

 

Interim Results for the six months ended 31 October 2013

 

Ilika (AIM: IKA), the advanced cleantech materials discovery company, announces its unaudited interim results for the six months ended 31 October 2013, a period of continued progress with technology development, new partnerships, contract renewals and increased business development activity in Europe.

 

Ilika accelerates the discovery of new and patentable materials using its unique high throughput technologies process for identified end uses in the energy, electronics, aerospace and biomedical sectors.

 

Operational Highlights

· Global OEM trials underway with two of Ilika's proprietary materials

· Grant of patent for low cost fuel cell catalyst in Japan

· Significant technical progress made in the development of proprietary solid state battery technology

 

Post Period End Events

· Notice of allowance for patent for fuel cell catalyst technology in Europe

· "World's first" for fabrication of a solid state battery that can be manufactured as a stack

 

Financial Summary

· Total revenue for the period (inc. grants) up 57% to over £0.6m (1H 2012; £0.4m)

· Gross margin up to 39% (1H 2012: 24%)

· R&D expenditure (mainly solid state battery technology) at comparable levels to 2012

· Substantial non-operational cost savings achieved across the group

· Operating loss reduced by 20% to £1.5m (1H 2012: £1.9m loss)

· Net Cash £1.4m (1H 2012: £3.6m)

 

Commenting on the results Ilika's Chairman, Jack Boyer, said: "The first six months of our current financial year have yielded significant progress. Firstly, global OEMs are actively evaluating two of Ilika's proprietary materials, most notably the fuel cell catalyst material, indicating that Ilika has made strong progress in licensing out its IP portfolio. This commercialisation activity has been underpinned by the further grant of patents in Ilika's key target markets. Secondly, the investment Ilika has made over the last 18 months in solid state battery technology has borne fruit, with Ilika able to declare a "world first" through the production of a battery architecture that can be manufactured as a continuous stack. This opens the door to rapidly growing opportunities to power wireless sensors and ultimately address the world's largest battery markets for consumer electronics through early adoption by the defence sector."

 

Ilika plc

Graeme Purdy, Chief Executive

Steve Boydell, Finance Director

+44 (0)23 8011 1400

 

 

NUMIS Securities Limited

Oliver Cardigan/ James Black

+44 (0) 20 7260 1000

 

Walbrook PR Ltd

+44 (0)20 7933 8780 or ilika@walbrookpr.com

Lianne Cawthorne (Media Enquiries)

Mob: +44 (0)7584 391 303

Paul Cornelius (Investor Enquiries)

Mob: +44 (0)7827 879 460

Joint Chairman's and CEO's Statement

Review of Period

 

Commercialisation progress

 

The Company has continued to make progress developing and licensing its proprietary materials IP. With the goal of driving towards generating licensing revenue, Ilika is currently managing active OEM trials with two separate products from its portfolio.

 

Low Cost Fuel Cell Catalyst

In a fuel cell, a controlled reaction between hydrogen and oxygen occurs. This reaction requires electro-catalysts, which are currently based on the precious metal, platinum. Ilika has developed a novel platinum-free catalyst, which on a cost/performance basis, promises to be 70 percent cheaper than the current industry standard.

 

The electro-catalysts have been manufactured to Ilika's specification by a partner using an industrially scalable process. Following the delivery of a kg-scale quantity of its catalyst, OEM trials have commenced with three global OEMs and a trial with a further automotive OEM will commence in Q1 2014.

In May 2013, Ilika received notification that its patent application covering the use of lower cost metal alloys as electro-catalysts in PEM (Proton exchange membrane) fuel cells has been granted in Japan. This is in addition to the grant of Ilika's patent in the USA, which was achieved last year.

Cell growth surface

The polymer surface is a non-core legacy product from its biomaterial portfolio and is being out-licensed on Ilika's behalf by BioBM, a specialist life science marketing company.

 

Project developments

 

Solid State Battery Technology

Ilika has achieved a world first in producing a single cell battery that is suitable for manufacturing as a stacked structure. This technical innovation enables Ilika to make larger batteries suitable for mainstream battery applications, including consumer electronics.

 

The mass-market commercialisation of solid state batteries will be a step change in the evolution of battery technology; enabling lighter, safer batteries charging up to 6x faster and lasting 4x longer between recharges than the highest performance lithium ion incumbents. Over the last 18 months, building on its unique material discovery platform and world-class expertise in thin film material synthesis, Ilika has been developing a proprietary solid state battery chemistry and fabrication process, facilitating the scale-up manufacture of the next generation of solid state lithium ion batteries. It has used its unique processing abilities to successfully turn a set of optimized high-performance materials into single-cell, solid state batteries with the following key properties:

 

· Thermal compatibility between components (resulting in a simple fabrication process),

· Mechanical stability (yielding a robust structure that remains intact over a large number of cycles),

· Stackable cells (necessary for building larger capacity batteries).

Electrochemical testing of the stacked cells is under way and is expected to be completed in Q1 2014. Successful test results would be hard evidence for Ilika's proprietary solid state battery processing, and would be the key milestone on the full commercialisation journey. This scalable stacked cell architecture enables the simple fabrication of cells over a wide range of sizes. Ilika intends to initially produce micro-battery prototypes designed for powering wireless sensors, which is a rapidly growing segment expected to create an addressable market for micro-batteries in excess of £1bn by 2017. The battery architecture will subsequently be scaled-up, using the same process but with faster fabrication rates, to produce prototypes suitable for the largest markets for lithium ion batteries in consumer electronics, including mobile phones, with early adoption foreseen through the defence and space sectors. The EPSRC grant announced in July provides all the required funding for the capital equipment needed for that scale-up. Ultimately, the technology could be scaled for larger format batteries for automotive and distributed energy storage applications. Ilika has already filed a portfolio of patent applications, some of which are jointly held with Toyota, to protect the considerable progress made so far, including:

· A method for depositing thin film phosphates,

· Unique and improved synthesis methods for thin film electrolytes and electrodes

· A unique method to deposit the components, enabling stacked thin film batteries.

This development accelerates Ilika's ongoing customer engagements with OEMs in the sensor, consumer electronics and automotive sectors across three continents.

 

Commercial project interactions

 

Ilika has expanded its active customer base in the period from five in the comparable period last year, to nine in the current year. The geographical spread of revenues has also become more balanced due to a stronger business development in Europe. In the previous year, 70% of revenues originated with Japanese customers, whereas in the current year to date, 45% of revenues have come from Europe and 45% from Japan.

 

Automotive Thin Film Battery Technology

Ilika's in-house solid state battery programme is an extension of the technology originally developed with Toyota for the creation of safer, lighter batteries with the ability to be rapidly charged and discharged in hybrid vehicles. Toyota remains Ilika's most important customer and continues to work closely together with Ilika in the development of battery materials, having extended their contractual arrangement through seven successive renewals over five years.

 

Aerospace

A new high growth sector for the Company's technology platform is the aerospace sector, where Ilika has entered into initial relationships with two of the world's largest aerospace companies. Further activities are expected to be supported by the Aerospace Technology Institute, which has recently been established to deploy £2 billion of funding for the UK aerospace industry over the next seven years.

 

Outlook

 

The management team remains committed to deploying Ilika's cash prudently to drive the Company towards profitability and beyond, while also supporting its solid state battery programme to deliver both its long-standing and new shareholders attractive returns on their investment.

 

Graeme Purdy, CEO

Jack Boyer, Chairman

Ilika plc

 

 

Consolidated statement of comprehensive income for the six months ended 31 October 2013

 

Unaudited Six months ended

31 Oct 2013

Unaudited Six months ended

31 Oct 2012

 

Audited Year

ended

30 Apr 2013

Notes

£

£

£

Continuing operations

Revenue

571,498

391,801

1,003,943

Cost of sales

(345,894)

(296,745)

(561,584)

Gross profit

225,604

95,056

442,359

Administrative expenses

(1,781,279)

(2,001,487)

(4,020,375)

Other operating income

42,310

118

17,133

Operating loss

(1,513,365)

(1,906,313)

(3,560,883)

Financial income

10,292

40,533

67,437

Financial expense

(1,513)

(2,270)

(4,575)

Loss before tax

(1,504,586)

(1,868,050)

(3,498,021)

Taxation

152,528

108,884

239,741

Loss for period on continuing

Activities

(1,352,058)

(1,759,166)

(3,258,280)

Loss for the period on discontinued activities

 

 

(210,524)

 

(216,693)

Loss and total comprehensive

income and expense for the period

(1,352,058)

(1,969,690)

(3,474,973)

Loss per share

2

Basic

(0.03)

(0.04)

(0.07)

Diluted

(0.03)

(0.04)

(0.07)

Continuing operations

(0.03)

(0.04)

(0.06)

Discontinued operations

(0.00)

(0.00)

(0.01)

 

Consolidated balance sheet as at 31 October 2013

 

Unaudited

Six months ended

31 Oct 2013

Unaudited

Six months ended

31 Oct 2012

Audited

Year

ended

30 Apr 2013

Notes

£

£

£

ASSETS

Non current assets

Intangible assets

7,048

55,550 

9,425 

Property, plant and equipment

737,690

1,110,279 

1,105,706 

Total non current assets

744,738

1,165,829 

1,115,131 

Current assets

Trade and other receivables

992,499 

555,889 

577,505 

Current tax receivable

113,548 

109,449 

230,000 

Other financial assets - bank deposits

293,007 

3,460,664 

1,455,092 

Cash and cash equivalents

1,129,738 

90,714 

407,970 

Assets classified as held for sale

70,447 

Total current assets

2,528,792 

4,287,163 

2,670,567 

Total assets

3,273,530 

5,452,992 

3,785,698 

EQUITY

Issued share capital

499,104 

475,354 

475,354 

Share premium

9,509,020 

8,823,770 

8,823,770 

Capital restructuring reserve

6,486,077 

6,486,077 

6,486,077 

Retained earnings

(13,995,750)

(10,838,139)

(12,643,692)

Total equity

2,498,451 

4,947,062 

3,141,509 

LIABILITIES

Current liabilities

Trade and other payables

775,079

505,137 

644,189

Liabilities classified as held for sale

-

793 

Total liabilities

775,079

505,930 

644,189

Total equity and liabilities

3,273,530

5,452,992 

3,785,698

 

 

 

 

 

Consolidated cash flow statement for the six months ended 31 October 2013

 

Unaudited

Six months ended

31 Oct 2013

Unaudited

Six months ended

31 Oct 2012

Audited

Year

ended

30 Apr 2013

£

£

£

Cash flows from operating activities

Loss for period on continuing activities

(1,504,586)

(1,868,050)

(3,498,021)

Loss for the period on discontinued activities

(210,524)

(216,693)

Adjustments for:

Amortisation

2,378

6,313 

52,438

Depreciation

366,088

386,777 

803,345

Equity settled share based payments

-

48,419 

(251,851)

(Profit)/loss on disposal of plant, property and

Equipment

 

(145)

 

 

155

Net financial income

(8,779)

(38,263)

(62,862)

Operating cash flow before changes in working capital, interest and taxes

(1,145,044)

(1,675,328)

(3,173,489)

Decrease/(increase) in trade and other

receivables

 

(454,994)

 

95,054

 

74,734 

Decrease in inventory

-

-

34,135 

Increase /(decrease) in trade and other payables

138,433

(318,208)

(175,966)

Cash utilised by operations

(1,461,605)

(1,898,482)

(3,240,586)

Tax received

268,980

124,905

124,905

Net cash flow from operating activities

(1,192,625)

(1,773,577)

(3,115,681)

Cash flows from investing activities

Interest received

10,292

33,189 

59,055 

Sale of discontinued operations

40,000

50,000 

Sale of property plant and equipment

2,450

Purchase of property, plant and equipment

(377)

(143,099)

(551,591)

Decrease in other financial assets

1,162,085

539,336 

2,544,908 

Net cash used in investing activities

1,214,450

429,426

2,102,372

Cash flows from financing activities

Proceeds from issuance of ordinary share capital

712,500

149,380

149,380 

Share issue costs

(3,500)

-

-

Capital element of finance leases

(7,544)

(11,317)

(22,633)

Interest element of finance leases

(1,513)

(2,270)

(4,540)

Net cash from financing activities

699,943

135,793

122,207

Net increase / (decrease) in cash and cash equivalents

721,768

(1,208,358)

(891,102)

Cash and cash equivalents at the start of the

Period

407,970

1,299,072

1,299,072 

Cash and cash equivalents at the end of the

Period

1,129,738

90,714

407,970

 

Consolidated statement of changes in equity (unaudited)

 

 

 

Share capital

Share premium account

Capital

restructuring reserve

 

Retained earnings

 

 

Total

£

£

£

£

£

As at 30 April 2012

472,638

8,677,106 

6,486,077 

(8,916,868)

6,718,953 

Issue of shares

2,716

146,664 

-

149,380 

Share based payment

-

-

48,419

48,419 

Loss and total

comprehensive income

 

-

 

-

 

 

(1,969,690)

 

(1,969,690)

As at 31 October 2012

475,354

8,823,770 

6,486,077 

(10,838,139)

4,947,062 

Share based payment

-

-

(300,270)

(300,270)

Loss and total

comprehensive income

 

-

 

-

 

 

(1,505,283)

 

(1,505,283)

As at 30 April 2013

475,354

8,823,770 

6,486,077 

(12,643,692)

3,141,509 

Issue of shares

23,750

685,250 

-

709,000 

Loss and total

comprehensive income

 

-

 

 

 

(1,352,058)

 

(1,352,058)

As at 31 October 2013

499,104

9,509,020 

6,486,077 

(13,995,750)

2,498,451 

 

Share capital

The share capital represents the nominal value of the equity shares in issue.

 

Share premium account

When shares are issued, any premium paid above the nominal value is credited to the share premium reserve.

 

Retained earnings

The retained earnings reserve records the accumulated profits and losses of the Group since inception of the business.

 

Capital restructuring reserve

The capital restructuring reserve arises on the accounting for the share for share exchange. It represents the difference between the value of the issued equity instruments of Ilika Technologies Limited immediately before the share for share exchange and the equity instruments of Ilika plc along with the shares issued to effect the share for share exchange.

 Notes to the consolidated financial statements

 

1. Accounting policies

 

Basis of preparation

 

The interim financial statements, which are unaudited, have been prepared on the basis of accounting policies consistent with International Financial Reporting Standards ("IFRSs") adopted by the European Union. The accounting policies are the same as applied in the Group's latest financial statements.

 

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim Financial Reporting'. Accordingly, whilst the interim financial statements have been prepared in accordance with IFRS they cannot be construed as being in full compliance with IFRS.

 

The financial information for the year ended 30 April 2013 does not constitute the full statutory accounts for that period. The Annual Report and Accounts for 30 April 2013 have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Accounts for 2013 was unqualified and did not include references to any matters which the auditors drew attention by way of emphasis without qualifying their report and did not contain statements under Section 498(2) or 498(3) of the Companies Act 2006.

 

Going concern

 

The financial statements are prepared on a going concern basis which the directors believe continues to be appropriate. The Group meets its day to day working capital requirements through existing cash resources which, at 31 October 2013, amounted to £1,422,744. The directors have prepared projected cash flow information for the period ending twelve months from the date of their approval of these financial statements. The Board is confident that further finance could be secured based on the future prospects of the business and previous experience in raising equity finance, but acknowledge that this would be dependent on market conditions. On the basis of this cash flow information the directors believe that the Group will be able to continue to trade for the foreseeable future.

 

2. Loss per share

 

Loss per ordinary share have been calculated using the weighted average number of shares in issue during the relevant financial periods. The weighted average number of equity shares in issue and the earnings, being loss after tax, are as follows:

 

Unaudited

Six months ended

31 Oct 2013

 

Unaudited

Six months ended

31 Oct 2012

 

Audited

Year

ended

30 Apr 2013

Number

Number

Number

Weighted average number of equity shares

49,691,004 

47,330,257 

47,431,258

£

£

Loss, being loss after tax

(1,352,058)

(1,969,690)

(3,474,973)

 

The loss attributable to ordinary shareholders and weighted average number of ordinary shares for the purpose of calculating the diluted earnings per ordinary share are identical to those used for basic earnings per share. This is because the exercise of share options and warrants would have the effect of reducing the loss per ordinary share and is therefore not dilutive under the terms of IAS 33.

 

 

 

 

 

- Ends -

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFLDLIISLIS
Date   Source Headline
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.